Recently, a study reported that IGFBP3 may play a role in the immune microenvironment in hypertrophic cardiomyopathy [44], but its role in glioma immune microenvironment is still unclear. This evidence concerns the gene IGFBP3 and hypertrophic cardiomyopathy.